Literature DB >> 27064936

Laparoscopic Splenectomy and Esophagogastric Devascularization for Liver Cirrhosis and Portal Hypertension Is a Safe, Effective, and Minimally Invasive Operation.

Haibo Yu1,2, Si Guo2,3, Liancai Wang1,2, Yadong Dong1,2, Guanjin Tian1,2, Senmao Mu1,2, Huifeng Zhang2,4, Deyu Li1,2, Sihai Zhao5.   

Abstract

BACKGROUND: In the recent years, laparoscopic splenectomy and esophagogastric devascularization (LSD) for liver cirrhosis and portal hypertension rapidly gained the interest of hepatobiliary surgeons due to its minimal invasion. This study aimed to gather and analyze available data from the observational studies that have compared LSD and open splenectomy and esophagogastric devascularization (OSD) for liver cirrhosis and portal hypertension.
MATERIALS AND METHODS: All the studies comparing LSD and OSD for liver cirrhosis and portal hypertension were searched on the available databases, including the Cochrane Central Register of Controlled Trials, Medline, Science Citation Index, EMBASE, China National Knowledge Infrastructure, Wanfang Database, and China Biomedical Database. Data were analyzed using Review Manager software version 5.0.
RESULTS: After the literature search, a total of 17 studies were included in the meta-analysis, which involved 1093 patients: 552 in the laparoscopic group and 541 in the open group. The laparoscopic group was shown to have a lower overall postoperative complication rate (0.43; 95% confidence interval [CI; 0.29-0.64]) than the open group (P < .0001), which was not associated with heterogeneity between the studies. The laparoscopic group was shown to have a lower intraoperative blood loss (-320.62; 95% CI [-552.35 to -88.9]), shorter time of oral intake (-29.08 hours; 95% CI [-35.28 to -22.88]), and shorter hospital stay (95% CI [-6.19 to -2.19]) than those of the open group (P < .00001). The operative time of the laparoscopic group was 42.16 minutes longer (95% CI [32.20-52.11]) compared with the open group (P < .00001). There was no significant difference of hospitalization costs between the studies.
CONCLUSION: This meta-analysis demonstrated that laparoscopic left lateral resection is a safe and feasible option associated with a reduced overall complication rate. The current evidence suggested that it could be performed routinely in liver centers.

Entities:  

Mesh:

Year:  2016        PMID: 27064936     DOI: 10.1089/lap.2016.0032

Source DB:  PubMed          Journal:  J Laparoendosc Adv Surg Tech A        ISSN: 1092-6429            Impact factor:   1.878


  10 in total

1.  Vagus nerve-preserving versus conventional laparoscopic splenectomy and azygoportal disconnection.

Authors:  Dou-Sheng Bai; Ping Chen; Sheng-Jie Jin; Jian-Jun Qian; Guo-Qing Jiang
Journal:  Surg Endosc       Date:  2017-11-03       Impact factor: 4.584

2.  Spleen bed laparoscopic splenectomy plus pericardial devascularization for elderly patients with portal hypertension.

Authors:  Cao Yan; Zeyuan Qiang; Shuai Jin; Haibo Yu
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2022-03-16       Impact factor: 1.627

3.  Laparoscopic splenectomy and esophagogastric devascularization combined with fast-track principles offers greater benefit for patients with portal hypertension.

Authors:  Dong Wang; Zhang Zhang; Rui Dong; Jianguo Lu; Jikai Yin
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2022-01-19       Impact factor: 1.627

4.  Non-invasive evaluation of liver stiffness after splenectomy in rabbits with CCl4-induced liver fibrosis.

Authors:  Ming-Jun Wang; Wen-Wu Ling; Hong Wang; Ling-Wei Meng; He Cai; Bing Peng
Journal:  World J Gastroenterol       Date:  2016-12-14       Impact factor: 5.742

5.  Laparoscopic distal splenoadrenal shunt for the treatment of portal hypertension in children with congenital hepatic fibrosis: A case report.

Authors:  Jin-Shan Zhang; Wei Cheng; Long Li
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

6.  Clinical value of liver and spleen shear wave velocity in predicting the prognosis of patients with portal hypertension.

Authors:  Yan Zhang; Da-Feng Mao; Mei-Wu Zhang; Xiao-Xiang Fan
Journal:  World J Gastroenterol       Date:  2017-12-07       Impact factor: 5.742

7.  Hepatic venous pressure gradient-guided laparoscopic splenectomy and pericardial devascularisation versus endoscopic therapy for secondary prophylaxis for variceal rebleeding in portal hypertension (CHESS1803): study protocol of a multicenter randomised controlled trial in China.

Authors:  Ruoyang Shao; Zhiwei Li; Jitao Wang; Ruizhao Qi; Qingbo Liu; Weijie Zhang; Xiaorong Mao; Xiaojing Song; Lei Li; Yanna Liu; Xin Zhao; Chuan Liu; Xun Li; Changzeng Zuo; Weidong Wang; Xiaolong Qi
Journal:  BMJ Open       Date:  2020-06-23       Impact factor: 2.692

8.  Efficacy and safety of laparoscopic splenectomy and esophagogastric devascularization for portal hypertension: A single-center experience.

Authors:  Shunzhen Zheng; Ping Sun; Xihan Liu; Guangbing Li; Wei Gong; Jun Liu
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

9.  Association Between Changes in Splanchnic Hemodynamics and Risk Factors of Portal Venous System Thrombosis After Splenectomy with Periesophagogastric Devascularization.

Authors:  Long Huang; Qingsheng Yu; Jiajia Wang
Journal:  Med Sci Monit       Date:  2018-06-25

10.  Prognostic scoring system of laparoscopic splenectomy in children with benign hematological diseases, a retrospective cohort study.

Authors:  Mohammad Gharieb Khirallah; Ibrahim Ali Kabbash; Nagi Ebrahim El-Dessouki
Journal:  Ann Med Surg (Lond)       Date:  2021-06-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.